| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/07/2005 | EP0638091B1 Improved solubilization and stabilization of factor viii complex |
| 12/07/2005 | EP0615451B1 Novel cytokine that binds cd30 |
| 12/07/2005 | CN1705746A Factor involved in metastasis and uses thereof |
| 12/07/2005 | CN1705741A Improved immunotherapy |
| 12/07/2005 | CN1705677A Anti-tumour compound |
| 12/07/2005 | CN1705639A Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
| 12/07/2005 | CN1704475A HBsAg fusion gene with carboxyl-end containing pre S2 immune determinant and protein thereof |
| 12/07/2005 | CN1704406A Intermediate for the preparation of epimino |
| 12/07/2005 | CN1704121A Anti-angiogenic compositions and methods of use |
| 12/07/2005 | CN1704117A Gene recombination human interferon alpha 2b liposome and injection, suppository, eye drop, sparying preparation and ointment thereof |
| 12/07/2005 | CN1704116A Anti-phlogistic anti-exudation meidcine |
| 12/07/2005 | CN1230540C Drosophila recombination-associated protein and methods for use |
| 12/07/2005 | CN1230539C Bacterial auto-inducer inactivation protein, its coded nucleic acid molecule and uses |
| 12/07/2005 | CN1230538C Immunological reagent specifically interreacting with the extracellular domain of the human zeta chain |
| 12/07/2005 | CN1230537C Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from fusion product in aspergillus |
| 12/07/2005 | CN1230536C Tie-2 ligands, methods of making and uses thereof |
| 12/07/2005 | CN1230535C Isolated peptides which form complexes with MHC molecule HLA-C-Clone 10 and uses thereof |
| 12/07/2005 | CN1230444C Use of HIV polypeptide or peptide or polynucleotide expression construct containing HIV-cell toxicant T-lymphocyte epitope |
| 12/07/2005 | CN1230442C GnRh antagonists being modified in positions 5 and 6 |
| 12/07/2005 | CN1230441C Integrin binding peptide derivatives |
| 12/07/2005 | CN1230416C Pharmaceutical compounds |
| 12/07/2005 | CN1230201C Blood-platelet specific mosaic immune globulin and its using method |
| 12/07/2005 | CN1230200C Stable enzymatic wound debrider |
| 12/07/2005 | CN1230199C Use of nitric oxide for treatment of airway constriction |
| 12/07/2005 | CN1230198C Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having G chronic hepatitis C infection |
| 12/07/2005 | CN1230197C Y-IFN liquid-droplet aerosol and method |
| 12/07/2005 | CN1230196C Erythropoiesis for treating anemia of family and raised animals |
| 12/07/2005 | CN1230152C Hydrogel particle formulations |
| 12/07/2005 | CN1230151C Non-invasive transdermal vaccination |
| 12/07/2005 | CN1230141C Improved stability for injection solutions |
| 12/06/2005 | US6972462 Compact high voltage ESD protection diode |
| 12/06/2005 | US6972350 Pest-resistant plants comprising a construct encoding a vacuole targeting sequence and avidin or streptavidin |
| 12/06/2005 | US6972341 Prodrugs of GABA analogs, compositions and uses thereof |
| 12/06/2005 | US6972323 Anti-Fas antibodies |
| 12/06/2005 | US6972322 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases |
| 12/06/2005 | US6972321 Monomeric protein of the TGF-β family |
| 12/06/2005 | US6972319 Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of use |
| 12/06/2005 | US6972318 Complex of a chaperone protein with amyloid |
| 12/06/2005 | US6972300 Compounds and compositions for delivering active agents |
| 12/06/2005 | US6972282 Process for producing a product containing antihypertensive tripeptides |
| 12/06/2005 | US6972281 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof |
| 12/06/2005 | US6972280 Purification of DNA encoding a numerous polypeptides useful for the stimulation of glial cell (particularly, Schwann cell) mitogenesis and treating glial cell tumors. Also disclosed are DNA sequences encoding novel polypeptide which |
| 12/06/2005 | US6972193 dimerization or oligomerization of intracellular proteins to activate genetic transcription; signal transduction and activators of transcription |
| 12/06/2005 | US6972187 OAT5 molecules and uses therefor |
| 12/06/2005 | US6972179 RRP sequences and knockout mice and uses thereof |
| 12/06/2005 | US6972171 mixing polynucleotides with folic acid, hormones, peptides, glycoproteins, lipids or phosphatides to form nucleotides used as drugs; genetic engineering; gene expression |
| 12/06/2005 | US6972170 obtaining sample of prostate carcinoma and detecting presence of p27 protein in prostate carcinoma, the absence of p27 indicating that the prostate carcinoma is aggressive |
| 12/06/2005 | US6972168 Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture |
| 12/06/2005 | US6972128 allogeneic immunotherapy; vaccines; immortalization |
| 12/06/2005 | US6972127 administering an effective dose of a polypeptide comprising an immunogenic fragment of A beta (SEQ ID NO:1) and an adjuvant in a regime effective to induce an immune response comprising antibodies to the A beta fragment; Alzheimer's disease |
| 12/06/2005 | US6972126 Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing same |
| 12/06/2005 | US6972124 Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 12/06/2005 | CA2362834C Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 12/06/2005 | CA2285700C Renin-active substance |
| 12/06/2005 | CA2208274C Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes |
| 12/06/2005 | CA2096528C Retroviral protease inhibitors |
| 12/06/2005 | CA2073282C Human herpesvirus type 6 protein p100, the corresponding dna sequences, their preparation and use |
| 12/01/2005 | WO2005114217A2 Na+ and ci> coupled transport system for endogenous opioid peptides |
| 12/01/2005 | WO2005114216A2 Stamp2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 12/01/2005 | WO2005114199A1 Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 5 (map3k5) |
| 12/01/2005 | WO2005113823A2 Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same |
| 12/01/2005 | WO2005113811A2 Combinatorial selection of phosphorothioate aptamers for tgf-beta |
| 12/01/2005 | WO2005113809A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 12/01/2005 | WO2005113799A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor kinase 5 (grk5) |
| 12/01/2005 | WO2005113786A2 Diagnostics and therapeutics for diseases associated with chymase (cma1) |
| 12/01/2005 | WO2005113720A2 A strategy for designing patient-specific anti-cancer drugs |
| 12/01/2005 | WO2005113606A2 Fgf-21 fusion proteins |
| 12/01/2005 | WO2005113605A1 Cross-linked antibodies |
| 12/01/2005 | WO2005113599A1 C1q family member proteins with altered immunogenicity |
| 12/01/2005 | WO2005113596A2 Cell surface receptor isoforms and methods of identifying and using the same |
| 12/01/2005 | WO2005113595A2 High affinity ny-eso t cell receptor |
| 12/01/2005 | WO2005113592A2 Interferon-alpha polypeptides and conjugates |
| 12/01/2005 | WO2005113591A1 Chimeric soluble hyper il-11 and use thereof |
| 12/01/2005 | WO2005113590A2 Bmp10 propeptides and related methods |
| 12/01/2005 | WO2005113589A2 Modified antigen-presenting cells |
| 12/01/2005 | WO2005113586A2 Disease-associated proteins |
| 12/01/2005 | WO2005113585A2 Modified tgf-beta superfamily polypeptides |
| 12/01/2005 | WO2005113582A1 Substituted ethane-1,2-diamines for the treatment of alzheimer's disease |
| 12/01/2005 | WO2005113581A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease |
| 12/01/2005 | WO2005113580A1 Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| 12/01/2005 | WO2005113579A1 Bacterial efflux pump inhibitors and methods of treating bacterial infections |
| 12/01/2005 | WO2005113490A1 Sulfone-containing prodrugs |
| 12/01/2005 | WO2005113236A2 Films comprising a liquid-absorbant inner layer, an antimicrobial material and an impermeable outer layer |
| 12/01/2005 | WO2005113059A2 Disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 12/01/2005 | WO2005113036A1 Method and apparatus for glucose control and insulin dosing for diabetics |
| 12/01/2005 | WO2005113030A1 Tissue closing preparation |
| 12/01/2005 | WO2005113023A1 Use of arginine and like substances and methylglyoxal and like substances in dialysis machines |
| 12/01/2005 | WO2005113019A2 Methods for the treatment of autoimmune diseases |
| 12/01/2005 | WO2005113007A2 Powders containing novel oligosaccharide mixtures and methods for producing the same |
| 12/01/2005 | WO2005113001A1 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 12/01/2005 | WO2005112998A2 Compositions and methods for preventing erythropoietin-associated hypertension |
| 12/01/2005 | WO2005112989A1 Protease inhibitors and their therapeutic applications |
| 12/01/2005 | WO2005112988A2 Methods for treating and diagnosing cancer with wnt inhibitory factor-1 (wif-1) |
| 12/01/2005 | WO2005112987A2 Method of preparation and use of fibrinolytic enzymes in the treatment of disease |
| 12/01/2005 | WO2005112986A2 Purifying chondroitinase and stable formulations thereof |
| 12/01/2005 | WO2005112984A2 Apparatus and method for transdermal delivery of parathyroid hormone agents |
| 12/01/2005 | WO2005112983A2 Modulation of immunoglobulin production and atopic disorders |
| 12/01/2005 | WO2005112982A1 Process for the isolation and/or purification of proteins |
| 12/01/2005 | WO2005112981A2 Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells |
| 12/01/2005 | WO2005112980A2 Bi-lateral local renal delivery for treating congestive heart failure and for bnp therapy |